文献速递脑血管病外科

中国东部地区颅内动脉瘤的治疗格局:技术采纳与结局的倾向性匹配分析(2018-2022年)

Treatment Landscape of Intracranial Aneurysms in Eastern China: A Propensity-Matched Analysis of Technique Adoption and Outcomes (2018-2022).
PubMed 文献 · World Neurosurg · 2025-05-16

该多中心回顾性研究纳入2018至2022年治疗的2720例患者共2811个颅内动脉瘤,比较显微外科夹闭与血管内栓塞的临床结局,并探讨影响治疗决策的临床与社会经济因素。倾向性匹配分析显示血管内栓塞手术时间更短、并发症更少,但费用更高且复发风险更高;血管内栓塞采用率显著上升,破裂动脉瘤复合年增长率为16.3%,未破裂动脉瘤为19.1%。

要点

  • 未破裂颅内动脉瘤患者中90%(1295/1439)接受血管内栓塞治疗。
  • 倾向性匹配后血管内栓塞手术时间更短、并发症更少,但费用更高、复发风险更高。
  • 血管内栓塞采用率上升,破裂动脉瘤复合年增长率16.3%,未破裂动脉瘤19.1%。

核心结论

  • 作者认为这是中国东部地区首个整合临床结局与社会经济因素的颅内动脉瘤多中心研究。
  • 研究结果提示血管内栓塞日益受到青睐,尤其对于未破裂颅内动脉瘤,但显微外科夹闭对于复杂病例仍不可或缺。
  • 两种方法各有优势,应结合临床疗效与经济现实加以考虑。

研究设计与样本

  • 多中心回顾性研究,纳入2018至2022年治疗的2720例患者共2811个颅内动脉瘤。
  • 采用倾向性评分匹配比较手术方式与临床结局,并用多因素logistic回归识别治疗选择的决定因素。
  • 采用复合年增长率计算年增长率。

主要发现

  • 1281例破裂颅内动脉瘤患者中,533例接受显微外科夹闭,748例接受血管内栓塞。
  • 1439例未破裂颅内动脉瘤患者中,1295例(90%)接受血管内栓塞治疗。
  • 倾向性评分匹配后分析显示,血管内栓塞手术时间更短、并发症更少,但费用更高且复发风险更高。
  • 血管内栓塞更倾向于用于未破裂颅内动脉瘤及格拉斯哥昏迷量表评分较高的患者,显微外科夹闭则用于复杂动脉瘤和重症临床病例。
  • 血管内栓塞采用率显著增加,破裂颅内动脉瘤复合年增长率为16.3%,未破裂颅内动脉瘤为19.1%。

临床怎么用

  • 作者认为血管内栓塞日益受到青睐,尤其对于未破裂颅内动脉瘤,但显微外科夹闭对于复杂病例仍不可或缺。
  • 作者认为两种方法各有优势,应结合临床疗效与经济现实加以考虑。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To analyze treatment trends and outcomes for intracranial aneurysms (IAs) in Eastern China, comparing microsurgical clipping (SC) and endovascular coiling (EC), and exploring clinical and socioeconomic factors influencing treatment decisions. METHODS: A multicenter retrospective study of 2720 patients with 2811 aneurysms treated between 2018 and 2022 was conducted. Propensity score matching compared surgical procedures and clinical outcomes, while multivariable logistic regression identified determinants of treatment choice. Annual growth rates were calculated using compound annual growth rate. RESULTS: Of 1281 patients with ruptured IAs, 533 underwent SC and 748 received EC. For 1439 patients with unruptured IAs (UIAs), 1295 (90%) were treated with EC. Post-propensity score matching analysis showed EC had shorter operative times, fewer complications, but higher costs and recurrence risks. EC was preferred for UIAs and patients with higher Glasgow Coma Scale scores, while SC was chosen for complex aneurysms and severe clinical cases. Notably, EC adoption increased significantly, with a compound annual growth rate of 16.3% for ruptured IAs and 19.1% for UIAs, highlighting a shift toward technological preference. CONCLUSIONS: This is the first multicenter study on IA treatment in Eastern China, integrating clinical outcomes with socioeconomic factors. Findings suggest EC is increasingly favored, particularly for UIAs, but SC remains essential for complex cases. Both approaches offer distinct advantages and should be considered in the context of clinical efficacy and economic realities.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Pan X, Zhang R, Zhou T, et al. Treatment Landscape of Intracranial Aneurysms in Eastern China: A Propensity-Matched Analysis of Technique Adoption and Outcomes (2018-2022). World Neurosurg. 2025. PMID: 40383266. doi:10.1016/j.wneu.2025.124097

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。